IV Vasoactive Intestinal Peptide improves survival from Respiratory failure in COVID-19.

A recent study that was published in Critical Care Medicine found that Aviptadil, a synthetic form of vasoactive intestinal peptide (VIP) can improve the likelihood of survival from respiratory...

Related Keywords

,Critical Care Medicine ,Intestinal Peptide ,Patients With Critical ,Day Randomized Controlled Trial ,Crit Care ,Vasoactive Intestinal Peptide ,Aviptadil ,Critical Covid 19 ,Respiratory Failure ,Randomized Controlled Trial ,Ynthetic Vip ,Cytokine Storm ,